| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a2f4764f69c1e0a3d5acc7c11e74004 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-2093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-1418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-2027 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate |
2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce73e5b58feb44c1c32a5126defc42c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_416d6bdae325582026510f95aac6e29e |
| publicationDate |
2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019063735-A1 |
| titleOfInvention |
LIQUID DOSAGE FORM OF CAPTOPRIL AND DISTRIBUTION SYSTEM |
| abstract |
The invention relates to a container comprising a pharmaceutical dosage form, the pharmaceutical dosage form comprising solid and liquid components; the solid component comprising: captopril as active ingredient; and at least one water-soluble excipient; the liquid component comprising: water; sodium metabisulphite; at least one sequestering agent; and optionally other excipients; the container having two separate compartments separated by a breakable barrier, the solid component being located in a first compartment and the liquid component being located in a second compartment; the breakable barrier being designed to be ruptured by a user to allow the solid component and the liquid component to mix to provide the dosage form to be used. |
| priorityDate |
2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |